Rainmed Medical (HKSE:02297) EBIT per Share : HK$-0.10 (TTM As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Rainmed Medical EBIT per Share?

Rainmed Medical's EBIT per Share for the six months ended in Jun. 2024 was HK$-0.04. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.10.

During the past 3 years, the average EBIT per Share Growth Rate was -53.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Rainmed Medical's EBIT per Share or its related term are showing as below:

HKSE:02297' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -53.9 Med: -53.9 Max: -53.9
Current: -53.9

During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of Rainmed Medical was -53.90% per year. The lowest was -53.90% per year. And the median was -53.90% per year.

HKSE:02297's 3-Year EBIT Growth Rate is ranked worse than
94.92% of 708 companies
in the Medical Devices & Instruments industry
Industry Median: 6 vs HKSE:02297: -53.90

Rainmed Medical's EBIT for the six months ended in Jun. 2024 was HK$-45.20 Mil.

Rainmed Medical EBIT per Share Historical Data

The historical data trend for Rainmed Medical's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rainmed Medical EBIT per Share Chart

Rainmed Medical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EBIT per Share

-0.15

-0.67

-1.68

-0.11

Rainmed Medical Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT per Share	Get a 7-Day Free Trial			-1.23	-0.12	-0.05	-0.06	-0.04

Rainmed Medical EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Rainmed Medical's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-126.637	/	1167.799
=	-0.11

Rainmed Medical's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-45.203	/	1167.799
=	-0.04

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.10

Rainmed Medical (HKSE:02297) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Rainmed Medical EBIT per Share Related Terms

Thank you for viewing the detailed overview of Rainmed Medical's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Rainmed Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rainmed Medical Ltd (HKSE:02297) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 99, Jinji Lake Avenue, Building 31, Northeast District, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215000

Website

https://www.rainmed.com

Rainmed Medical Ltd is focused on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microcirculatory resistance systems. The company's core products, the caFFR system and the caIMR system are medical devices used to evaluate the severity of myocardial ischemia arising from coronary artery stenosis and microvascular dysfunction, which are the underlying causes of coronary artery diseases (CAD). It operates in China and Other countries.

Executives

Huo Yunfei	2101 Beneficial owner
Huo Yunlong
Zhou Bin
Zhong Guo Ping An Bao Xian Ji Tuan Gu Fen You Xian Gong Si
Xi Zang Jing Jia Qi Ye Guan Li You Xian Ze Ren Gong Si
Shang Hai Jing Lin Gu Quan Tou Zi Guan Li You Xian Gong Si
Shang Hai Jing Wu Tou Zi Zhong Xin You Xian He Huo
Shang Hai Jing Mai Run Qi Ye Guan Li Zhong Xin You Xian He Huo
Gong Qing Cheng Jing Cheng Yu Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Gong Qing Cheng Jing Lin Jing Jia Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Jing Lin Zi Ben Guan Li You Xian Gong Si
Shen Zhen Jing Lin Jing Ying Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo
Shen Zhen Jing Hui Gu Quan Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Shang Hai Tong Xiang Hao Qian Qi Ye Guan Li He Huo Qi Ye You Xian He Huo
Xi Zang Jing Ning Qi Ye Guan Li You Xian Ze Ren Gong Si

Rainmed Medical Headlines

No Headlines